Weekly Insulin: A New Approach to Diabetes Management

Created using ChatSlide

Awiqli® insulin icodec-abae offers a revolutionary approach to managing type 2 diabetes with weekly basal coverage, transitioning from daily injections to a single weekly dose. Its mechanism involves albumin binding for gradual insulin release, boasting a half-life of approximately 196 hours. Administration requires site rotation and the use of a U-700 pen for safety. Comprehensive safety profiles highlight adverse effects, contraindications, and necessary glucose monitoring, supported by...